Allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A single center experience.

about

Allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A single center experience.

Item

http://www.wikidata.org/entity/Q40829969

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Allogeneic hematopoietic cell ...... s: A single center experience.

@en

type

Item

label

Allogeneic hematopoietic cell ...... s: A single center experience.

@en

prefLabel

Allogeneic hematopoietic cell ...... s: A single center experience.

@en

P1476

Allogeneic hematopoietic cell ...... s: A single center experience.

@en

P2093

Christiane Groh

http://www.w3.org/2001/XMLSchema#string

Christoph Faul

http://www.w3.org/2001/XMLSchema#string

Dominik Schneidawind

http://www.w3.org/2001/XMLSchema#string

Joerg U Schmohl

http://www.w3.org/2001/XMLSchema#string

Lothar Kanz

http://www.w3.org/2001/XMLSchema#string

Robert Möhle

http://www.w3.org/2001/XMLSchema#string

Stefan Wirths

http://www.w3.org/2001/XMLSchema#string

Wichard Vogel

http://www.w3.org/2001/XMLSchema#string

Wolfgang A Bethge

http://www.w3.org/2001/XMLSchema#string

P2860

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

Hematopoietic Cell Transplantation as Curative Therapy for Patients with Myelofibrosis: Long-Term Success in all Age Groups

Primary chronic myelofibrosis: clinical and prognostic evaluation in 336 Japanese patients.

Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Biology and clinical management of myeloproliferative neoplasms and development of the JAK inhibitor ruxolitinib

Allogeneic transplantation for primary myelofibrosis with BM, peripheral blood or umbilical cord blood: an analysis of the JSHCT

Outcome of transplantation for myelofibrosis.

Somatic mutations of calreticulin in myeloproliferative neoplasms.

Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioning.

P304

973-983

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00277-016-2644-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27021303

http://www.w3.org/2001/XMLSchema#string